Brisbane Clinical Trials
The Influenza Study
The study drug is a potential new mRNA vaccine for the influenza virus.
0 nights
1 vaccine visit + 1 follow-up phone call + 6 visits
Study Objective:
- Develop vaccines to protect against prevalent influenza strains for the year.
Understanding Influenza:
- A respiratory virus with multiple strains, potentially causing annual epidemics.
Importance of Prevention:
- Vaccination can prevent virus spread and reduce flu-related mortality.
Clinical Trial Details:
- Testing vaccine efficacy, overseen by an independent ethics committee.
- An independent ethics committee has approved this clinical trial.
- Participants will be reimbursed for their time & commitment to the study completion.
Eligibility
Biological Sex Male or Female
Age 18 - 49 years old
BMI 18 - 35kg/m²
Medication Stable medications are permitted on a case-by-case basis
Medical conditions Stable medical conditions are permitted on a case-by-case basis
Smoking History Non-smokers or casual smokers (<10 cigarettes/week)